FR2299025B1 - - Google Patents

Info

Publication number
FR2299025B1
FR2299025B1 FR7602553A FR7602553A FR2299025B1 FR 2299025 B1 FR2299025 B1 FR 2299025B1 FR 7602553 A FR7602553 A FR 7602553A FR 7602553 A FR7602553 A FR 7602553A FR 2299025 B1 FR2299025 B1 FR 2299025B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7602553A
Other languages
French (fr)
Other versions
FR2299025A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2299025A1 publication Critical patent/FR2299025A1/fr
Application granted granted Critical
Publication of FR2299025B1 publication Critical patent/FR2299025B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7602553A 1975-02-03 1976-01-30 Compositions diuretiques Granted FR2299025A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54659075A 1975-02-03 1975-02-03

Publications (2)

Publication Number Publication Date
FR2299025A1 FR2299025A1 (fr) 1976-08-27
FR2299025B1 true FR2299025B1 (show.php) 1980-06-20

Family

ID=24181101

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7602553A Granted FR2299025A1 (fr) 1975-02-03 1976-01-30 Compositions diuretiques

Country Status (8)

Country Link
AU (1) AU507494B2 (show.php)
BE (1) BE838170A (show.php)
CA (1) CA1075155A (show.php)
DE (1) DE2603890A1 (show.php)
FR (1) FR2299025A1 (show.php)
GB (1) GB1501592A (show.php)
NL (1) NL7600500A (show.php)
ZA (1) ZA76565B (show.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399427A1 (fr) 1977-08-04 1979-03-02 Rolland Sa A Nouveaux sels d'addition hydrosolubles de l'acide tienilique
EP0083779B1 (en) * 1982-01-04 1987-01-21 Karl H. Beyer, Jr. Hyperuretic agents
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Also Published As

Publication number Publication date
BE838170A (fr) 1976-08-02
ZA76565B (en) 1977-09-28
AU1061176A (en) 1977-08-04
FR2299025A1 (fr) 1976-08-27
DE2603890A1 (de) 1976-08-05
GB1501592A (en) 1978-02-15
AU507494B2 (en) 1980-02-14
CA1075155A (en) 1980-04-08
NL7600500A (nl) 1976-08-05

Similar Documents

Publication Publication Date Title
FR2313891B1 (show.php)
FR2335255B1 (show.php)
IN144575B (show.php)
JPS5652660B2 (show.php)
FR2299025B1 (show.php)
FR2302607B3 (show.php)
JPS51114180U (show.php)
JPS51119458U (show.php)
JPS529948Y2 (show.php)
JPS5614193Y2 (show.php)
JPS5277374U (show.php)
JPS51109879U (show.php)
IN139887B (show.php)
JPS5260713U (show.php)
JPS5217182U (show.php)
JPS5194572A (show.php)
JPS5194147U (show.php)
JPS51153467U (show.php)
JPS51140915U (show.php)
JPS51124410U (show.php)
CH597496A5 (show.php)
CH598646A5 (show.php)
CH598737A5 (show.php)
CH596450A5 (show.php)
CH591324A5 (show.php)

Legal Events

Date Code Title Description
ST Notification of lapse